Another leukemia study showed that KMT2D occupied and activated pro-tumorigenic HOXA9 target genes and that KMT2D was required for leukemogenesis mediated by co-expression of HOXA9 and MEIS1in vivo [38]. Here, KMT2D is linked to leukemia.